Company: Dr. Reddy's Laboratories Ltd. Category: Company News

The complaint involves 30 generic drugs, 42 companies; DRL denies wrongdoing, says will vigorously defend itself
Feb. 4, 2019, 5:18 p.m.

It may be recalled that the company's net profit had declined 29 per cent in the year ago period
Feb. 1, 2019, 5:10 p.m.

Pharma major Dr Reddy's Laboratories Thursday said it has appointed Axis Bank's former MD and CEO Shikha Sharma as company's independent additional director for five years.
Feb. 1, 2019, 5:06 a.m.

The drug is indicated for the acute treatment of migraine with or without aura in adults.
Jan. 28, 2019, 8:34 a.m.

Dr Reddy's said it uses distribution controls to market Propofol Injectable Emulsion, USP, to prevent any misuse
Jan. 24, 2019, 12:55 p.m.

The Forms were issued after the completion of audit of the plant on January 15.
Jan. 16, 2019, 8:22 a.m.

Drug major Dr Reddy's Laboratories has launched Sevelamer Carbonate for oral suspension, in the US market.
Dec. 28, 2018, 10:35 a.m.

Quoting IMS Health data, Dr Reddy's Laboratories said the Aggrenox brand and generic had US sales of approximately $182 million for the most recent 12 months ending in October 2018
Dec. 24, 2018, 11:40 a.m.

Shares of Dr Reddy's were trading 0.20 per cent higher at Rs 2,695 apiece on the BSE
Dec. 11, 2018, 11:05 a.m.

Chlorthalidone tablets USP in the strengths of 25 mg and 50 mg
Nov. 28, 2018, 11:20 a.m.